Represented Vertos Medical, Inc. in its Series B Preferred Stock financing, raising $28 million. The round was led by MVM Life Science Partners with additional investments coming from Leerink Revelation Partners, Pitango Venture Capital, ONSET Ventures and Aweida Venture Partners. The money raised will be used to expand commercialization of its proprietary mild® procedure as well as for physician training and education.
Vertos Medical, Inc. develops and markets medical devices used to treat common spinal diseases. They are known for developing the mild® procedure, an outpatient procedure designed to help patients diagnosed with lumbar spinal stenosis stand longer and walk farther with less pain.
The Newport Beach-based team representing Vertos Medical included Bruce Feuchter, Jeff Estes, and Arash Lessantiz.